MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 525365 | Name: Pirenperone

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pirenperone is a 5-HT2 serotonin receptor antagonist.

Chemical Structure

Pirenperone
Pirenperone
CAS#75444-65-4

Theoretical Analysis

MedKoo Cat#: 525365

Name: Pirenperone

CAS#: 75444-65-4

Chemical Formula: C23H24FN3O2

Exact Mass: 393.1853

Molecular Weight: 393.46

Elemental Analysis: C, 70.21; H, 6.15; F, 4.83; N, 10.68; O, 8.13

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Pirenperone
IUPAC/Chemical Name
3-[2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one
InChi Key
HXCNRYXBZNHDNE-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H24FN3O2/c1-16-20(23(29)27-12-3-2-4-21(27)25-16)11-15-26-13-9-18(10-14-26)22(28)17-5-7-19(24)8-6-17/h2-8,12,18H,9-11,13-15H2,1H3
SMILES Code
O=C1C(CCN2CCC(C(C3=CC=C(F)C=C3)=O)CC2)=C(C)N=C4N1C=CC=C4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 393.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Nagakura I, Dunn TW, Farah CA, Heppner A, Li FF, Sossin WS. Regulation of protein kinase C Apl II by serotonin receptors in Aplysia. J Neurochem. 2010 Nov;115(4):994-1006. doi: 10.1111/j.1471-4159.2010.06986.x. Epub 2010 Oct 5. PubMed PMID: 20964689. 2: Regina MJ, Winter JC, Rabin RA. Characterization of a novel effect of serotonin 5-HT1A and 5-HT2A receptors: increasing cGMP levels in rat frontal cortex. Neuropharmacology. 2003 Dec;45(8):1041-9. PubMed PMID: 14614947. 3: Winter JC, Eckler JR, Rabin RA. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli. Psychopharmacology (Berl). 2004 Mar;172(2):233-40. Epub 2003 Nov 4. PubMed PMID: 14598016. 4: Winter JC, Fiorella DJ, Helsley SE, Rabin RA. Partial generalization of (-)DOM to fluvoxamine in the rat: implications for SSRI-induced mania and psychosis. Int J Neuropsychopharmacol. 1999 Sep;2(3):165-172. PubMed PMID: 11281985. 5: McHale NG, Thornbury KD, Hollywood MA. 5-HT inhibits spontaneous contractility of isolated sheep mesenteric lymphatics via activation of 5-HT(4) receptors. Microvasc Res. 2000 Nov;60(3):261-8. PubMed PMID: 11078642. 6: O'Dell LE, Kreifeldt MJ, George FR, Ritz MC. The role of serotonin(2) receptors in mediating cocaine-induced convulsions. Pharmacol Biochem Behav. 2000 Apr;65(4):677-81. PubMed PMID: 10764922. 7: Winter JC, Filipink RA, Timineri D, Helsley SE, Rabin RA. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors. Pharmacol Biochem Behav. 2000 Jan 1;65(1):75-82. PubMed PMID: 10638639. 8: Colpaert FC. Drug discrimination in neurobiology. Pharmacol Biochem Behav. 1999 Oct;64(2):337-45. Review. PubMed PMID: 10515310. 9: Lovren F, Li XF, Lytton J, Triggle C. Functional characterization and m-RNA expression of 5-HT receptors mediating contraction in human umbilical artery. Br J Pharmacol. 1999 Jul;127(5):1247-55. PubMed PMID: 10455272; PubMed Central PMCID: PMC1566120. 10: Winter JC, Timineri D. The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba. Pharmacol Biochem Behav. 1999 Mar;62(3):543-7. PubMed PMID: 10080249. 11: Misane I, Johansson C, Ogren SO. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Br J Pharmacol. 1998 Oct;125(3):499-509. PubMed PMID: 9806333; PubMed Central PMCID: PMC1565647. 12: Griebel G, Rodgers RJ, Perrault G, Sanger DJ. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacol Biochem Behav. 1997 Aug;57(4):817-27. PubMed PMID: 9259011. 13: Ritz MC, George FR. Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors. Psychopharmacology (Berl). 1997 Feb;129(4):299-310. PubMed PMID: 9085399. 14: Wainscott DB, Lucaites VL, Kursar JD, Baez M, Nelson DL. Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences. J Pharmacol Exp Ther. 1996 Feb;276(2):720-7. PubMed PMID: 8632342. 15: Young R, Glennon RA. A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA. J Pharmacol Exp Ther. 1996 Feb;276(2):594-601. PubMed PMID: 8632326. 16: Le Grand B, Talmant JM, Rieu JP, Patoiseau JF, Colpaert FC, John GW. Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potential. J Cardiovasc Pharmacol. 1995 Nov;26(5):803-9. PubMed PMID: 8637196. 17: Smith RL, Barrett RJ, Sanders-Bush E. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor. J Pharmacol Exp Ther. 1995 Nov;275(2):1050-7. PubMed PMID: 7473132. 18: Callahan PM, Cunningham KA. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J Pharmacol Exp Ther. 1995 Sep;274(3):1414-24. PubMed PMID: 7562516. 19: Powell KR, Dykstra LA. The role of serotonin in the effects of opioids in squirrel monkeys responding under a titration procedure: I. Kappa opioids. J Pharmacol Exp Ther. 1995 Sep;274(3):1305-16. PubMed PMID: 7562503. 20: Griebel G, Blanchard DC, Jung A, Masuda CK, Blanchard RJ. 5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone. Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):235-44. PubMed PMID: 7667334.